Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphoma

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 2, 2010, Pages 513-520

  Liu, Hong Wei ^a,b   Seftel, Matthew D ^a,b   Rubinger, Morel ^a,b   Szwajcer, David ^a,b   Demers, Alain ^a,b   Nugent, Zoann ^a   Schroeder, Garry ^a,b   Butler, James B ^a,b   Cooke, Andrew ^a,b  

^a CancerCare Manitoba ^*  (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

BEAM regimen; interstitial pneumonitis; Non Hodgkin's lymphoma; peripheral blood stem cell transplantation; total body irradiation

Indexed keywords

BEAM REGIMEN; INTERSTITIAL PNEUMONINITIDES; NON-HODGKIN'S LYMPHOMA; PERIPHERAL BLOOD; TOTAL BODY IRRADIATION;

ABERRATIONS; BLOOD; CHEMOTHERAPY; IRRADIATION; ONCOLOGY; TOXICITY;

STEM CELLS;

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE TOXICITY; ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANADA; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER RESISTANCE; CANCER STAGING; CATARACT; COHORT ANALYSIS; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEMENTIA; DIARRHEA; DISEASE FREE SURVIVAL; DRUG FATALITY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SKIN MANIFESTATION; SURVIVAL RATE; TREATMENT OUTCOME; WHOLE BODY RADIATION; ANALYSIS OF VARIANCE; AUTOTRANSPLANTATION; DRUG RESISTANCE; EVALUATION STUDY; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; MORTALITY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RADIATION PNEUMONITIS; TIME; YOUNG ADULT;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, NON-HODGKIN; MALE; MANITOBA; MELPHALAN; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RADIATION PNEUMONITIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 79958709167     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.08.024     Document Type: Article

References (35)

1. T. Philip, C. Guglielmi, and A. Hagenbeek Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma N Engl J Med 333 1995 1540 1545
2. I.W. Flinn, and J.G. Berdeja Blood and bone marrow transplantation for patients with Hodgkin's and non-Hodgkin's lymphoma Cancer Treat Res 131 2006 251 281
3. K. van Besien, F.R. Loberiza Jr., and R. Bajorunaite Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma Blood 102 2003 3521 3529 (Pubitemid 37409366)
4. E.D. Thomas, and R.B. Epstein Bone marrow transplantation in acute leukemia Cancer Res 25 1965 1521 1524
5. M.M. Qasim Total body irradiation in non-Hodgkin lymphoma Strahlentherapie 149 1975 364 367
6. I. Kazem Total body irradiation in the management of malignant lymphoma Radiol Clin (Basel) 44 1975 457 463
7. T. Philip, J.O. Armitage, and G. Spitzer High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma N Engl J Med 316 1987 1493 1498
8. P. Crilley, H. Lazarus, and D. Topolsky Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies Semin Oncol 20 1993 50 54 quiz 55
9. J.M. Vose, J.R. Anderson, and A. Kessinger High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma J Clin Oncol 11 1993 1846 1851
10. F. Gutierrez-Delgado, D.G. Maloney, and O.W. Press Autologous stem cell transplantation for non-Hodgkin's lymphoma: Comparison of radiation-based and chemotherapy-only preparative regimens Bone Marrow Transplant 28 2001 455 461
11. A. Salar, J. Sierra, and M. Gandarillas Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: The role of preparative regimens Bone Marrow Transplant 27 2001 405 412
12. National Cancer Institute and U.S. National Institutes of Health. CTC v2.0 and Common Terminology Criteria for Adverse Events v3.0 (CTCAE). 9-Aug-2006. https://webapps.ctep.nci.nih.gov/webobjs/ctc/webhelp/welcome-to- ctcae.htm. Date accessed on 27-Sep-09.
13. The Center for International Blood and Marrow Transplant Research (CIBMTR). Hodgkin and non-Hodgkin lymphoma: 095-LYM (PDF). April 1998. http://www.cibmtr.org/DATA/Report-Forms/Lymphomas/DOCS/095lym.pdf. Date accessed on 27- sep-09.
14. M. de Lima, R.E. Champlin, and P.F. Thall Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome Leukemia 22 2008 258 264
15. O.F. Ballester, D.P. Agaliotis, and J.W. Hiemenz Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: Toxicities and hematopoietic recovery Bone Marrow Transplant 18 1996 9 14
16. T. Demirer, C.H. Weaver, and C.D. Buckner High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy J Clin Oncol 13 1995 596 602
17. F. Heinzelmann, H. Ottinger, and C.H. Muller Total-body irradiation - Role and indications: Results from the German registry for stem cell transplantation (DRST) Strahlenther Onkol 182 2006 222 230
18. T. Philip, P. Biron, and D. Maraninchi Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non-Hodgkin's lymphoma Br J Haematol 60 1985 599 609 (Pubitemid 15002280)
19. T. Philip, P. Biron, and P. Herve Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin's malignant lymphoma with a very bad prognosis Eur J Cancer Clin Oncol 19 1983 1371 1379
20. R.S. Stein, J.P. Greer, and S. Goodman Is total body irradiation a necessary component of preparative therapy for autologous transplantation in non-Hodgkin's lymphoma Leuk Lymphoma 41 2001 97 103 (Pubitemid 32294193)
21. H.B. Kal, M. Loes van Kempen-Harteveld, and M.H. Heijenbrok-Kal Biologically effective dose in total-body irradiation and hematopoietic stem cell transplantation Strahlenther Onkol 182 2006 672 679
22. F. Gutierrez-Delgado, L. Holmberg, and H. Hooper Autologous stem cell transplantation for Hodgkin's disease: Busulfan, melphalan and thiotepa compared to a radiation-based regimen Bone Marrow Transplant 32 2003 279 285
23. C. Emmanouilides, D.J. Asuncion, and C. Wolf Localized radiation increases morbidity and mortality after TBI-containing autologous stem cell transplantation in patients with lymphoma Bone Marrow Transplant 32 2003 863 867
24. M. Beyzadeoglu, K. Oysul, and B. Dirican Effect of dose-rate and lung dose in total body irradiation on interstitial pneumonitis after bone marrow transplantation Tohoku J Exp Med 202 2004 255 263
25. S. Sampath, T.E. Schultheiss, and J. Wong Dose response and factors related to interstitial pneumonitis after bone marrow transplant Int J Radiat Oncol Biol Phys 63 2005 876 884
26. G. Akpek, R.F. Ambinder, and S. Piantadosi Long-term results of blood and marrow transplantation for Hodgkin's lymphoma J Clin Oncol 19 2001 4314 4321
27. J.G. Berdeja, R.J. Jones, and M.L. Zahurak Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma Biol Blood Marrow Transplant 7 2001 561 567
28. Y.L. Kasamon, R.J. Jones, and L.F. Diehl Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma Biol Blood Marrow Transplant 11 2005 39 46
29. Y.L. Kasamon, R.J. Jones, and S. Piantadosi High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement Biol Blood Marrow Transplant 11 2005 93 100
30. A. Barrett, M.H. Depledge, and R.L. Powles Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation Int J Radiat Oncol Biol Phys 9 1983 1029 1033
31. C.I. Chen, R. Abraham, and R. Tsang Radiation-associated pneumonitis following autologous stem cell transplantation: Predictive factors, disease characteristics and treatment outcomes Bone Marrow Transplant 27 2001 177 182
32. F.M. Khan, J.F. Williamson, and W. Sewchand Basic data for dosage calculation and compensation Int J Radiat Oncol Biol Phys 6 1980 745 751
33. S.L. McAfee, S.N. Powell, and C. Colby Dose-escalated total body irradiation and autologous stem cell transplantation for refractory hematologic malignancy Int J Radiat Oncol Biol Phys 53 2002 151 156
34. R.M. Sobecks, C.K. Daugherty, and D.E. Hallahan A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies Bone Marrow Transplant 25 2000 807 813
35. R.A. Clift, C.D. Buckner, and F.R. Appelbaum Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: A randomized trial of two irradiation regimens Blood 76 1990 1867 1871